Wire · regulatory
Tandem Mobi sees FDA clearance for tubeless AID system
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 16 November 2026 · Fusion42 review
Tandem Mobi has received FDA clearance for its tubeless Automated Insulin Delivery (AID) system, marking a significant regulatory milestone in diabetes management technology in the United States.
This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it between 13 Nov 2026 and 16 Nov 2026.
◆ ◆ The Wire takeaway
The FDA clearance opens a direct sales path for you in US diabetes treatment tech and sets a benchmark your rivals will chase. Expect faster adoption but also more competition from this point.
◆ Coverage
2 sources · first reported 13 Nov 2026 · latest 16 Nov 2026
◆ Related on Wire
◆ Topics